阴道联合直肠黄体酮在HRT-FET中能否达到最佳黄体酮范围
前瞻性队列研究纳入277例HRT-FET周期,其中239周期联合阴道(90mg/12h)与直肠(90mg/12h)黄体酮并测血清黄体酮。血清黄体酮中位45nmol/l,高黄体酮组(>45nmol/l)持续妊娠率显著低于中间组(28-45nmol/l),OR 0.56(95%CI 0.32-0.98;P=0.04)。直肠给药不适耐受良好,阴道不适随时间增加。
要点
- 联合阴道与直肠黄体酮使血清黄体酮中位达45nmol/l。
- 高血清黄体酮(>45nmol/l)与持续妊娠率降低相关。
- 直肠黄体酮不适报告率低且稳定,阴道不适随时间显著增加。
核心结论
- HRT-FET周期中联合直肠与阴道黄体酮可获得较高的血清黄体酮水平,但存在上限阈值,超过该浓度持续妊娠率下降。
研究设计与样本
- 前瞻性队列研究,n=277,含239个HRT-FET周期,联合阴道(90mg/12h)与直肠(90mg/12h)黄体酮,第6天移植单囊胚,收集134份便利性与副作用问卷。
主要发现
- 血清黄体酮中位45nmol/l(范围2-150nmol/l)。
- 总体阳性HCG率62%,第12周持续妊娠率44%,流产率29%。
- 血清黄体酮与持续妊娠率呈非线性关系。
- 高黄体酮组(>45nmol/l)持续妊娠率粗比值比0.56(95%CI 0.32-0.98;P=0.04),对照中间组(28-45nmol/l)。
- 直肠给药不适在移植日与5周后妊娠扫描日分别报告18%(16/87)和17%(8/47);阴道给药不适从18%(16/87)增至45%(21/47)(P<0.002)。
临床怎么用
- HRT-FET中联合阴道与直肠黄体酮可提高血清黄体酮水平,但需警惕过高水平可能降低持续妊娠率。
- 直肠黄体酮耐受性较好,阴道不适随时间增加,咨询时可告知患者。
局限性
- 为前瞻性队列研究,非随机对照,可能存在混杂。
- 问卷回复仅134份,副作用数据不完整。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: What is the ongoing pregnancy rate (OPR) in frozen embryo transfer (FET) cycles, using combined rectal and vaginal progesterone in hormonal replacement therapy (HRT)? DESIGN: A prospective cohort study (n = 277) including 239 HRT-FET cycles with serum progesterone measurements studying combined vaginal (90 mg/12 h) and rectal (90 mg/12 h) progesterone administration and single blastocyst transfer on the sixth day of progesterone administration. A total of 134 responses to questionnaires covering convenience and side-effects were collected. RESULTS: The median serum progesterone level was 45 nmol/l (range 2-150 nmol/l). Overall positive HCG rate, OPR at week 12 and pregnancy loss rates were 62%, 44% and 29%, respectively. A non-linear relationship between serum progesterone levels and OPR was found. Crude odds ratio for OPR in the high progesterone group (>45 nmol/l) was 0.56 (95% CI 0.32 to 0.98; P = 0.04) compared with the intermediate progesterone group (28-45 nmol/l). Discomfort after rectal progesterone administration was reported on the embryo transfer day and on the day of pregnancy scan 5 weeks later by a total of 18% (16/87) and 17% (8/47) of patients, respectively. Discomfort related to vaginal administration increased significantly over time and was reported by 18% (16/87) on the day of embryo transfer compared with 45% (21/47) on the day of pregnancy scan (P < 0.002). CONCLUSIONS: Combined rectal and vaginal progesterone in HRT-FET cycles resulted in higher median progesterone levels compared with vaginal administration alone. This study suggests that an upper threshold for serum progesterone exists and that above this concentration serum progesterone levels decrease the OPR. Rectally administered progesterone was well tolerated by patients.
引用
- Alsbjerg B, Thomsen L, Elbaek HO, et al. Can combining vaginal and rectal progesterone achieve the optimum progesterone range required for implantation in the HRT-FET model? Reprod Biomed Online. 2020. PMID: 32376312. doi:10.1016/j.rbmo.2020.02.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。